Doctors Tame One Of Cancer's Deadliest Forms NPR Thu, 29 Jan 2009 2:57 AM PST The chances of surviving cancer have been increasing in recent years. One of the most dramatic success stories in cancer care involves multiple myeloma — among the deadliest types of the disease. Doctors say new drugs can suppress the bone marrow cancer for years. | Winning The War On Cancer: The Critical Role Of Radiation Oncology Medical News Today Thu, 29 Jan 2009 3:20 AM PST A group of radiation oncology providers, manufacturers and patient groups today gathered to raise awareness about one of the least understood cancer treatments: radiation therapy. Every year, more than 1 million cancer patients receive radiation treatment. | New Data Published In Immunobiology Describe Mode Of Action Of BiTE Antibody MT110 Medical News Today Thu, 29 Jan 2009 3:22 AM PST Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced publication of new data in the peer-reviewed journal Immunobiology describing in detail the mode of action of BiTE antibody MT110. | ZenBio, Inc. Awarded $1.88 Million Phase II SBIR Grant For Mesothelial Cell Program Medical News Today Thu, 29 Jan 2009 3:19 AM PST ZenBio, Inc. announced that it has been awarded a Phase II SBIR grant to commercialize primary human peritoneal mesothelial cells. The $1.88 million award from the National Institutes of Health will fund continued optimization and commercial development of this unique tool for cancer, obesity, and type 2 diabetes research. | The Gate wins charity-backed anti-obesity brief Mad.co.uk Thu, 29 Jan 2009 2:57 AM PST The Gate has won a Government-funded anti-obesity brief being put together by the charities British Heart Foundation (BHF), Cancer Research UK and Diabetes UK. | | |
|
No comments:
Post a Comment